Tuesday 30 April 2019

Irritable Bowel Syndrome Treatment Market Detailed Growth Analysis To 2025


Irritable bowel syndrome is a gastrointestinal tract disorder characterized by abdominal pain and altered bowel habits. It hampers the natural movement of intestinal muscle linings to move food along the digestive tract. Depending on the symptoms, the syndrome is distinguished as mild and severe irritable bowel syndrome. These symptoms include cramping, abdominal pain, bloating and gas, mucus in the stool, constipation, and diarrhea. Exact cause of occurrence of irritable bowel syndrome is unknown though, it is associated with increased awareness of bodily functions, and abnormal gastrointestinal tract movements. Diagnosis of irritable bowel syndrome is done by tests such as blood tests, stool tests, endoscopic procedures and external imaging procedures. Patients suffering from irritable bowel syndrome may experience complications namely, deep ulcerations, infections, and malnutrition and bowel obstructions. Treatment of irritable bowel syndrome involves relieving the patient from the symptoms and improving the quality of life.


Market Dynamics

The rise in number of gastrointestinal disorders are leading to increasing prevalence of irritable bowel syndrome, for which various companies such as Ironwood Pharmaceuticals, Inc. as well as NGOs conduct mass workshops for educating the people to incorporate healthy food habits as a major precaution towards prevention of IBS. Furthermore, major growth drivers for the irritable bowel syndrome treatment market are expected launches of various pipeline drugs for the treatment during the forecast period and increase in levels of stress associated with changing lifestyle as people suffering from IBS have a colon with sensitivity towards certain foods and stress. According to a survey by Buscopan IBS Relief in 2016, stress was the cause for seven out of ten patients suffering from gastrointestinal pain. The large population of stress and anxiety disorder patients are expected to fuel the growth of the global irritable bowel syndrome treatment market.

The global irritable bowel syndrome treatment market was valued at US$ 726.1 million in 2016 and is expected to witness a robust CAGR of 12.9% over the forecast period (2017-2025).

Increase in levels of stress and adoption of sedentary lifestyle is expected to increase the prevalence of lifestyle disorders namely irritable bowel syndrome

The number of available irritable bowel syndrome drugs has increased over the last few years and new drugs have been approved for the treatment. North America accounts for the largest share in the global irritable bowel syndrome treatment market, followed by Europe and Asia-pacific, respectively. According to an article published in the Brandon Gaille in 2017, on an average, junk food accounts for 28.8% of the total caloric intake of an American. According to Centers for Disease Control and Prevention (CDC) in 2015, it was estimated that 1.3% of U.S. adults i.e. 3 million were reported to being diagnosed with IBD. Consumption of unhealthy food in large quantities raises the bar of probability for IBS acting as a driving factor for the global market growth.

Global Key Players

Some major players operating in the irritable bowel syndrome treatment market are Abbott Laboratories, Synergy Pharmaceuticals, Inc., Sucampo Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Ardelyx, Inc., Astellas Pharma Inc., Novartis AG, GlaxoSmithKline plc., and Ironwood Pharmaceuticals, Inc.

Detailed Segmentation:

Global Irritable Bowel Syndrome Treatment Market, By Drug Type:
  • Lubiprostone
  • Linaclotide
  • Eluxadoline
  • Rifaximin
  • Ramosetron Hydrochloride
  • Others

Global Irritable Bowel Syndrome Treatment Market, By Medical Condition:
  • IBS-Constipation
  • IBS-Diarrhea


About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702

Automatic Cell Imaging System Market Value Projected to Expand by 2018-2026


Live cell imaging, or cell imaging is the examination of living cells using time-lapse microscopy (time-lapse photography applied to microscopy). Cell Imaging is used by scientists to get a better understanding of the biological functions of the body in the course of the study of cellular dynamics. The process was established in first half of the 20th century. The first time-lapse microcinematographic films showed the development and fertilization of a sea urchin egg. Various methods of microscopy have since been developed, thereby allowing researchers to experiment on living cells with greater detail and with less effort. A new kind of imaging, which uses quantum dots, has been pioneered as they are found to be more stable.

Get Free Exclusive PDF Sample Copy of This Report @ https://www.coherentmarketinsights.com/insight/request-pdf/499

Cell imaging has become an important tool in medical research. Automatic microscopy and image analysis are used to study a variety of different things such as the influence of chemical compounds on cell development. Researchers in this field primarily want to see which compounds capture the cell cycle or the time they take to incubate and at what concentration. Cell cycle is a rigid sequence of phases that a cell undergoes while it is on its dividing phase. If anything goes wrong at some stage during the transition from one phase to other, the cell generally enters cell death that is programmed. Studying these procedures needs intricate image analysis workflows that can be mind-numbing to ascertain. This process is sped up by the use of modular software. Automated cell imaging also find its usage in the drug discovery processes for various diseases, for instance, cancer drugs. As the prevalence of cancer around the world is rising at an alarming rate, the automatic cell imaging system market is likely to gain significant traction during the forecast period.

High prevalence of cancer will drive the overall automatic cell imaging system market

According to the National Cancer Institute, an estimated 1,685,210 new cases of cancer were diagnosed in the U.S. alone and around 595,690 people died from the disease in 2016. The most common cancers were breast cancer, colon and rectum cancer, kidney and renal pelvis cancer, prostate cancer, non-Hodgkin lymphoma, leukemia, thyroid cancer, lung and bronchus cancer, melanoma of the skin, bladder cancer, pancreatic cancer, and endometrial cancer. The quantity of new cases of cancer was 454.8 per 100,000 women and men per year (statistic based on 2008-2012 cases). Additionally, the number of deaths due to cancer was 171.2 per 100,000 women and men per year (statistic based on 2008-2012 cases). As the occurrence of cancer is rising at an alarming rate, so is the need for automatic cell imaging system. Automatic cell imaging system offers grass root level analysis of the division of cancer cells and hence researchers are using this technique to find a cure to the fatal disease. This is likely to fuel the growth of the overall automatic cell imaging system market.

Top Movers of The Market

Some of the key players operating in the global automatic cell imaging system market are GE Healthcare Life Sciences, West Medica, Norma Diagnostika GmbH, Bioview, Caliber I.D., Molecular Devices, BioTek Instruments, and PerkinElmer.

Automatic Cell Imaging System Market Taxonomy -

On the basis of type of product,

  • Phase contrast microscopy
  • Fluorescent microscopy
  • Quantitative phase contrast microscopy

On the basis of end user,

  • Research centers
  • Hospitals
  • Others

Find the comprehensive research report here with a single click: https://www.coherentmarketinsights.com/ongoing-insight/automatic-cell-imaging-system-market-499

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702

Monday 29 April 2019

Medical Breathable Tapes Market Latest Key Development and Dynamics


Medical breathable tape, also known as surgical tape is a pressure-sensitive adhesive tape used in first aid and medicine, commonly to hold a bandage onto a wound. Breathable tapes usually have a hypoallergenic adhesive, which is specially designed for firm holding onto skin and can be removed easily without damaging the skin. They are termed breathable as they easily allow air to reach the skin. Latex free medical grade adhesive offers a major advantage with patients suffering from sensitive and fragile skin. The breathable tapes such as Kinesiology Tape are elastic bandages with adhesives made of cotton. Surgical tapes contains zinc oxide which help in preventing infections. 3M tape made of microporous material are widely used post surgeries.


The common types of medical breathable tapes are:

  1. Medical Adhesive Tape : Also known as surgical tape, made with zinc oxide to reduce the risk of infection. The breathable nature allows air circulation which kills the bacteria and allows the wound to heal faster. Various materials are used for making these tapes, they include, silk, nylon, plastics, foam and paper
  2. Cloth Adhesive Tape: They are adhesive tapes made from cloth and offer durability and flexibility. They are used to secure ventilation tubes, intravenous lines and other devices in place.
  3. Pressure sensitive adhesive tape: The pressure tape is wrapped on the wound to prevent movement and minimize friction. They are commonly available in first aids for securing bandages on the wounds. The adhesive is made of hypoallergenic material which does not leave any residue and can be painlessly removed. They are used by athletes on elbows, ankles for securing joints by giving them support.
  4. Waterproof tape: Owing to the hydroscopic nature of the tape, water does not penetrate the bandage and helps in preventing infection. The tape acts as insulator preventing blood from crossing the barrier, keeping the wound more sterile. They are commonly found in clinics, hospitals.
  5. Micro pore tape: Also called paper tape, it is commonly used with people having sensitive and delicate skin. The elder people with thin skin are commonly treated by applying micro pore tape. The pores make the tape breathable and provides germ free environment.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/488

Alternative wound care products restraining the market growth

Although the number of surgeries performed every year is increasing globally owing to increasing incidence of chronic diseases and accidents, impact of alternative wound care and closure products is expected to the restrain the market growth. Use of adhesives and sealants counters the market growth of medical breathable tapes. However, demand for medical breathable tapes is still significant in emerging economies where the penetration of newer wound care products is still lower compared to developed economies such as the U.S., Canada, Germany, France and the U.K.

3M is at the forefront for adhesive innovation with a commitment to enhance patient safety

Key players operating in the medical breathable tapes market are 3M, DYNAREX, Medtronic, and Medline Industries. 3M is expected to dominate the global market with the production of innovatory adhesives like Universal Cloth Adhesive Tape to enhance patient safety. Other vendors focusing on strengthening their global presence by introducing inexpensive products include NICHIBAN, BSN Medical, McKesson, Johnson & Johnson Consumer Companies, DUKAL, Smith & Nephew plc.

The global medical breathable tapes market is segmented on the basis of product type, end user and geography.

Based on the product type, the global medical breathable tapes market is segmented into:

  • Medical Breathable Poly Ethylene Tape
  • Medical Breathable Non-woven Tape
  • Waterproof Zinc Oxide Adhesive Cloth Tape
  • Medical Rayon Tape
  • Zinc Oxide Adhesive Cloth Tape
  • Easy-tear Non-woven Cloth Tape
  • Others

Find the comprehensive research report here with a single click: https://www.coherentmarketinsights.com/ongoing-insight/medical-breathable-tapes-market-488

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702

Tuesday 23 April 2019

Carbon Nanotubes (CNT) Market Insight & Geographical Expanse until 2026


Carbon nanotubes (CNTs) are cylindrically shaped structures with diameter of one-billionth of a meter, which is 100 times stronger and just one-sixth as heavy as steel. The high strength and low weight combined with physical flexibility is the most noteworthy property of carbon nanotubes. Carbon nanotubes exhibit higher thermal and electrical conductivity than conventional copper tubes. Carbon nanotubes are increasingly being used as an efficient tool in transporting drug molecules, while it plays a major role in body implants, dental filling, and medical device components. CNTs are functionalized with bioactive peptides, proteins, nucleic acids, and drugs for targeted drug delivery to the cells and organs. Carbon nanotubes assure low toxicity and are not immunogenic, due to which it has potential application in the field of nanomedicine and nanobiotechnology, among others.

Download PDF Brochure of This Business Report @ https://www.coherentmarketinsights.com/insight/request-pdf/469

Increasing healthcare applications to boost market growth

According to a study conducted by The University of Cambridge, in 2016, the global CNT production capacity has increased tenfold over the last 5 years due to exponential rise in demand for carbon nanotubes across various industries such as electronics, semiconductors, chemical & polymers, advanced materials, and batteries & capacitors is driving growth of the carbon nanotubes market. Furthermore, increasing incorporation of carbon nanotubes in the healthcare sector for therapies such as cancer, hyperthermia, gene therapy, tissue regeneration, and artificial implants is drastically driving growth of the carbon nanotube market. Its superior mechanical & transport properties are the major factors for growth of the carbon nanotubes market.

Financial backing from government bodies to boost market growth in Asia Pacific

Europe is expected to hold the largest market share, owing to high incidence of cancer in the region. According to the research published by National Centre of Biotechnology Information in Europe in 2012, 29,300 cancer cases were registered every year and carbon nanotubes proved an effective diagnostics in curing the major types of cancer. Increasing government investments in research and development in the field of nanotechnology integrated with healthcare is driving growth of the carbon nanotubes market.

The use of carbon nanotube scaffolds in tissue engineering represent a promising carbon nanotube market

Key players operating the carbon nanotubes market include CNano Technology Limited, Hanwha Nanotech Corporation, Kumho Petrochemical Company Ltd. Scaffold designing and fabrication are major areas of biomaterial synthesis, which have increased the demand for carbon nanotubes, in turn boosting market growth. Other prominent participants include Showa Denko, Carbon Solutions, Future Carbon GmbH, and Continental Carbon Nanotechnologies Inc.

Advent of multi-wall carbon nanotubes fueling market growth

On the basis of product type, the carbon nanotubes market is segmented into:

  • Single wall carbon nanotubes
  • Multi wall carbon nanotubes

On the basis of application, the carbon nanotubes market is segmented into:

  • Targeted drug delivery
  • Tissue engineering
  • Gene therapy
  • Cancer therapy


About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702

Monday 22 April 2019

Excimer Laser Devices Market to Hold a High Potential for Growth by 2026


An excimer laser, or exciplex laser, is an ultraviolet form of laser. Excimer laser devices find application in eye surgery, production of microelectronic equipment, micromachining, and manufacturing of semiconductor based integrated circuits or chips. An excimer laser mainly consists of reactive gases such as fluorine or chlorine coupled with noble gases, including argon, krypton, and/or xenon. Unlike conventional lasers, laser action in an excimer laser arises from repulsive or dissociative ground state as opposed to being in an excited state. This is due to the fact that noble gases such as krypton and xenon are highly inactive and generally do not form chemical compounds. Nevertheless, when they are in an excited state (induced by a high energy electron beam or an electrical discharge), they can form momentarily bound molecules with themselves known as dimmers or with halogens such as fluorine or chlorine, known as complexes. The compound in its excited state can release its excess energy by undergoing stimulated or spontaneous emission, thereby giving rise to a strongly repulsive molecule in its ground state which dissociates into two unbound atoms on the order of picoseconds. This is the basic functioning of an excimer laser device.

Download PDF Brochure of This Business Report @ https://www.coherentmarketinsights.com/insight/request-pdf/462

The key industrial use of the excimer lasers is in microelectronic devices and equipment along with ultraviolet photolithography. Excimer lasers have significantly high power ultraviolet output which makes it very useful for surgeries. This is acting as a driving factor for the growth of the excimer laser devices market. Moreover, excimer lasers also find its application in research laboratory equipment. Most important applications of excimer lasers are photolithography for semiconductor chips, laser ablation, micro-structuring of transparent media, pulsed laser deposition, eye surgery, laser marking, psoriasis treatment and dye-laser pumping.

Rising number of surgeries and high application areas of excimer lasers will drive the overall excimer laser devices market

The lifespan of an excimer laser is mainly limited by gas contamination, corrosion processes, dust produced by electric discharge, apart from high voltage electronics. These are some of the restraining factors that might affect the market negatively during the forecast period. However, varied application areas of excimer laser devices such as medicine, construction, and semiconductor is likely to encourage the growth of the excimer laser devices market during the forecast period.

In 2016, North America held the maximum share of the market. The U.K., Germany, France, and Italy are some of the other countries which have a significant share of the market. The increasing volume of surgical procedures across the globe is likely to drive the overall growth of the digital wound management devices market during the forecast period. Surgeries are conducted to manage various diseases including gastrointestinal diseases, cardiovascular diseases, spinal abnormalities, urological disorders, orthopedic deformities, and brain tumors. The significant growth in the number of surgeries, especially in the European countries will help in the growth of the excimer laser devices market in this region. In the Asia Pacific region, Japan, China, India, and South Korea are the leading market players. In South America region, Brazil and Argentina are likely to boost the excimer laser devices market in this region.

Top Key Players

Some of the major companies operating in the excimer laser devices market are Alcon, Inc., Coherent, Inc., NIDEK Co. Ltd., Wavelength Opto Electronic (S) Pte Ltd., Laser 2000 GmbH, AMS Technologies AG, Ziemer Opthalmic Systems AG, and Radiant Dyes Laser & Accessories GmbH.

Excimer laser devices market Taxonomy

On the basis of application,

  • Coronary Atherectomy
  • Peripheral Vascular Disease
  • Removal of Cardiac Leads
  • Acute Myocardial Infarction and Saphenous Vein Grafts
  • Removal of Artery blockages

On the basis of end-user,

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

Find the comprehensive research report here with a single click: https://www.coherentmarketinsights.com/ongoing-insight/excimer-laser-devices-market-462

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702

Recombinant Vaccines Market Demand and Forecast to 2025


Recombinant vaccines are produced by using recombinant DNA technology or genetic engineering for the prevention of lethal diseases in human beings and animals. Recombinant vaccine is a biological preparation that provides active acquired immunity against a certain disease. Whereas individual being vaccinated produces antibodies against the protein antigen that protect a person from contracting the disease upon attack from the pathogenic microorganism. These vaccines functions on the immune response for diseases and to have preventive measures against diseases caused by various bacteria, and virus. These vaccines are much more advanced and effective as compare to conventional vaccines in the prevention of diseases such as malaria, typhoid, and human papillomavirus (HPV). Furthermore, Europe dominates the animal recombinant vaccines market as compared to other regions due to highly organized livestock and major demand for livestock products in Europe.

Get Free Exclusive PDF Sample Copy of This Report @ https://www.coherentmarketinsights.com/insight/request-pdf/455

Market Dynamics:

The recent past has witnessed a steady rise in incidence of zoonotic and infectious diseases in humans and animals as well, which lead to the increased research & developments for the innovation of new and effective recombinant vaccines for the prevention of diseases. Government has also taken an initiative to increase awareness regarding vaccination to prevent diseases in community. Manufacturing companies have also started some beneficial programs to provide vaccination free of cost to poor people, which creates a highly conducive environment for growth of the recombinant vaccines market in near future. National Immunization Program by Queensland Government in Australia and Indradhanush vaccination program in India works to provide vaccination among children throughout the nation. Various organizations such as World Health Organization, World Bank, and United Nations Children’s Funds has also taken and initiative to increase vaccination.

The global recombinant vaccine market was valued at US$ 830.2 million in 2016 and is expected to witness a robust CAGR of 6.0% during the forecast period (2017 – 2025).

Increase in the incidence of zoonotic diseases and emerging technologies expected to support the growth of recombinant vaccines market

There is a constant increase in diseases caused by bacteria or virus such as swine flu, malaria, HPV and other diseases, which has raised the demand of vaccination and lead to the eradication of diseases such as polio, and tetanus in few countries. Whit the development in technology there is development in vaccines, which are more effective than conventional vaccines and does not lead to any side effect. These vaccines are easy to administer in the body orally, intramuscular or intradermal. In the U.S. there were around 212 million malaria cases and 429,000 deaths from malaria is reported in 2015. According to Centers for Disease Control and Prevention report 2017, in the U.S. there were around 49.9% of the children between the ages of 6 months to 17 years received an influenza vaccine.

Top Key Players:

Some major key players in the recombinant vaccines market include Merck & Co. Inc., Novartis AG, Protein Science Corporation, GlaxoSmithKline Plc., Green Cross Corporation, Bayer AG, Sanofi S A, Pfizer Inc., and Bharat Biotech.

Detailed Segmentation:

Global Recombinant Vaccines Market, By Product Type -
  • Subunit Recombinant Vaccines
  • Attenuated Recombinant Vaccines
  • Vector Recombinant Vaccines

Global Recombinant Vaccines Market, By Disease Type -
  • Infectious Disease
  • Cancer
  • Allergy
  • Others

Find the comprehensive research report here with a single click: https://www.coherentmarketinsights.com/market-insight/recombinant-vaccine-market-455

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702

Knee Braces Market increasing Business Opportunities by 2026


Knee bracing devices are orthopedic tools that are mainly used for alignment, pain reduction and maintenance of structural and functional characteristics of the knee. Knee braces offer protection to the knees of patients suffering from osteoarthritis as well as are used in the treatment of meniscus injuries. Apart from these, knee braces can be used as safety devices while playing various sports such as running and soccer and are also used in injury rehabilitation. These are generally worn in case of knee pain. Knee braces are made from one or more combination of rigid and flexible materials like metal, plastic, moldable foam, synthetic rubber, padding or elastic material and straps. These knee braces are available is several sizes and have provisions for pressure adjustments. On the other hand, custom knee braces are designed in a way to perfectly fit the exact knee measurements.

Click the link to Get a Free Sample Copy of the Report: https://www.coherentmarketinsights.com/insight/request-sample/440

Increasing Knee injuries along with Osteoarthritis contributing to the boost of global knee braces market

The knee braces consumption is mostly driven by patients suffering from osteoarthritis. According to WHO, over 20% of the world’s population aged over 60 that accounts for around 130 million people will suffer from osteoarthritis by the 2050. Additionally, the National Institute of Health reported 6,664,324 knee injuries in the U.S. from 1999 to 2008 and is expecting a significant in increase in this number by 2020. These estimates suggests a drastic boost for the global knee braces market during the forecast period.

North America to hold largest share of the global knee braces market owing to increased osteoarthritis cases

On the basis of regional segmentation, the knee braces market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is the largest shareholder of the global market, followed by Europe. According to Centers for Disease Control and Prevention (CDC), around 30 million adults in the U.S. are affected with osteoarthritis in 2016 suggesting high consumption of knee braces for the treatment of this disease in the U.S.

High incidence rates of osteoarthritis and meniscus injuries are responsible for driving the global knee braces market

The prevalence and incidence rate of Osteoarthritis and meniscus injuries among the geriatric population are the primary reasons to drive the global knee braces market. The United Nations suggests that number of people aged over 60 years is projected to grow by 56%, accounting a rise from 901 million to 1.4 billion in the years 2015 to 2030. Moreover, according to the CDC data in 2015, 23.7 million adults in the U.S. have functional limitations in their regular movements due to doctor diagnosed arthritis suggesting strong probabilities of prevalence of osteoarthritis.

Major Players

The key players dominating the global knee braces market includes Alex Orthopedic Inc., Body Sport, Bell Horn, Cho-Pat, DJO Global, Medi-Dyne and Medline. These companies are holding a strong position in the global knee braces market due to high R&D investment costs and long term contract relationship with the customers.

The global knee braces market can be segmented on the basis of product type, end user and geographical regions.

On the basis of types of braces available,

Rehabilitative braces: These are involves in providing stability to allow a limited movement while an injury is healing.
Unloader braces: These braces are generally used by people suffering from arthritis to relieve the pain.
Prophylactic braces: These are the protective braces generally worn to avoid knee injuries during sports. These braces are commonly used by athletes.
Knee Sleeves: These are support devices that are used to provide compression around the knee joints are used for knee support and controlling pain and swelling around the knee area.

Find the comprehensive research report here with a single click: https://www.coherentmarketinsights.com/ongoing-insight/knee-braces-market-440

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702

Saturday 20 April 2019

Coronary Stents Market to Surpass US$ 13.0 billion by 2026

Increasing product launches coupled with increasing geographical approval in drug eluting coronary stents is propelling growth of the coronary stents market. For instance, in May 2018, Abbott received the U.S. FDA approval for XIENCE Sierra, the new generation of everolimus-eluting coronary stent. The XIENCE received approval from the Japan’s regulatory body in April 2018, and CE mark from European regulatory bodies in 2017. Furthermore, companies are also evaluating and launching products with novel material, such as with metal like cobalt chromium and fully biodegradable stents.
For instance, in 2017, Medtronic received approval for Onyx drug eluting stents from the U.S. FDA for the treatment of coronary artery disease in adults. In the same year, company also received approval for cobalt chromium coronary stent system, known as Pro-Kinetic energy stents after BIOHELIX-I studies.
Furthermore, in 2017, Cordis launched two products: the Tryton Side Branch Stent and Medinol’s NIRxcell, a cobalt-chromium bare metal stent (BMS) under comprehensive interventional cardiology portfolio at 29th Transcatheter Cardiovascular Therapeutics Symposium. Such product launches in symposiums and conferences are expected to highlight the product and its features to healthcare professionals and distributors, in turn aiding in increasing the customer base of the company.
Mergers and acquisition by key players are further augmenting the coronary stents market growth with major players enhancing their market share and leveraging the strengths of the acquired company. For instance, in February 2018, Stentys confirms its rights to acquire MINVASYS, a France-based cardiovascular disorder solutions specialist, to accelerate its development and to establish as a benchmark in interventional cardiology market.
Moreover, increasing expansion of regional key players in the other regions is also expected to influence the regional market growth. For instance, in April 2018, Terumo Corporation, Tokyo-based medical device company, received CE mark for Ultimaster TANSEI drug-eluting stent, which was launched in the European market in May 2018. Furthermore, the company also aims to expand in Middle East, Latin America, and Asia in the near future.
Major players operating in the coronary stents market include Boston Scientific Corporation, Abbott, Medtronic plc, B. Braun Melsungen AG, Stentsy SA, Terumo Interventional Systems, Kyoto Medical Planning Co., Ltd., QualiMed, Elixir Medical Corporation, ENDOCOR GmbH, BIOTRONIK SE & Co. KG, Amaranth Medical, Inc. and Arterial Remodeling Technologies SA
Major players operating in the coronary stents market include Boston Scientific Corporation, Abbott, Medtronic plc, B. Braun Melsungen AG, Stentsy SA, Terumo Interventional Systems, Kyoto Medical Planning Co., Ltd., QualiMed, Elixir Medical Corporation, ENDOCOR GmbH, BIOTRONIK SE & Co. KG, Amaranth Medical, Inc. and Arterial Remodeling Technologies SA
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, 
#3200 
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Friday 19 April 2019

Medical Fiber Optics Market - Global Industry Size, Share, Outlook, and Analysis, 2018-2026

Medical endoscopic applications are served by employing optical fibers in the endoscopy systems. Optical fiber technology is being widely used in imaging, illumination, laser delivery systems, and biosensors. In case of observation and illumination of organs and cells, the advantages offered by optical biomedical sensors such as small size, low weight, and biocompatibility with MRI and CT are helpful. Optical fiber sensors consists of a light source, photo detector, optical fiber, and external transducer. Moreover, lasers, surgical lights, and dental lights have specialized applications, as it helps physicians in various respective areas.
Request for a sample of this research report @ https://www.coherentmarketinsights.com/insight/request-sample/1645
Minimally invasive surgeries offer significant reduction in postoperative pain, decreased recovery time, and reduced hospital stays. Applications such as minimally invasive robotic surgery, optical fiber lasers, and detection of diseases through sensors could be potential sources of revenue stream in medical fiber optics market. More importantly, minimally invasive robotic surgeries is a growing trend in the medical field and as these systems utilize advanced endoscopes, laser guiding systems, and optical visualization systems, the need for optical fiber based products is expected to increase over the forecast period. This, in turn will boost growth of the global medical fiber optics market. Furthermore, rising prevalence of diseases such as cancer and cardiovascular disease is expected to boost growth of the market over the forecast period.
According to the American Cancer Society, in 2017, cancer was the second most common cause of death in the U.S., which accounts for nearly 1 out of every 4 deaths. Biomedical sensors is another such area, which has high applications in drug discovery, disease diagnosis, and pathology. Glucometers is a prime example of biosensor technology, which is utilized for the management of glucose content in the blood. Wearable technology is a booming field in biosensors, which is further expected to foster the growth of medical fiber optics market. Medical imaging has become a primary diagnostic tool in many medical emergencies, which utilize optical fiber technologies and continuous demand for these products is expected to support growth of the medical fiber optics market.
Request for Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/1645
However, most of the medical devices utilizing fiber optic technology are installed once and used repetitively. Moreover, the cost of installation of these devices is high, which is expected to restrain growth of the global medical fiber optics market over the forecast period.
Manufacturers such as Schott AG (Europe) and Corning, Inc. (U.S.) offer products in these regions. Leoni AG launched an optical fiber in 2017 that is capable of indicating changes in temperature, pressure, and other parameters and could be applied in medical applications. Moreover, the Fiber Optic Sensing Association (FOSA), the first trade association dedicated to fiber-optic sensing is also present in the U.S. since April 2017. Asia Pacific region is expected to show significant growth, owing to high patient base requiring medical imaging procedures for various conditions such as cancer.
Key players operating in the medical fiber optics market include Corning, Inc., Optical Cable Corporation, AFL, Coherent, Inc., Sterlite Technologies Limited, Schott AG, Leoni AG, Rofin, IPG Photonics, Timbercon Inc., and OFS Fitel, LLC.
Make an inquiry for purchasing this report @ https://www.coherentmarketinsights.com/insight/buy-now/1645
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, 
#3200 
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Thursday 18 April 2019

Capnography Devices Market Growth, Trends, and Forecast 2018–2026


Capnography is the process of extensive measurement and display of concentrations or partial pressures of carbon dioxide (CO2) in the respiratory gases by using a capnograph. It accurately measure the levels of carbon dioxide released into the bloodstream. The readings are presented as a graph of expiratory CO2 plotted against time or expired volume called as capnogram. A capnogram is direct monitoring of inhaled and exhaled concentrations of CO2 and an indirect monitoring of CO2 in arterial blood. There is a very small difference in pressure between arterial blood and exhaled CO2 among healthy individuals. On the other hand, a large difference between arterial blood and exhaled gas, sometimes exceeding 1kPa, is observed in people suffering from various forms of lung diseases and some forms of congenital heart diseases.

Download PDF Brochure of This Business Report @ https://www.coherentmarketinsights.com/insight/request-pdf/433

Capnography majorly depicts all the three components of respiration: metabolism, transport, and ventilation and therefore gives an excellent picture of the respiratory process. This is a major help for people who suffer from asthma and chronic obstructive pulmonary disease (COPD) as it will help in proper patient monitoring and take further medications accordingly. The American Society of Anesthesiologists (ASA) endorses end-tidal capnography as a standard of care for general anesthesia, deep sedation and moderate sedation. Other specialties include critical care and emergency medicine.

Rising demand for effective monitoring of carbon dioxide levels was limited due to involvement of pulse oximetry, which takes 4-5 minutes to reflect respiratory status of the individual while capnographs provides the ventilation status of individuals in real time, thereby improving patient care. According to the American Thoracic Society, approximately 360,000 respiratory failure cases every year are observed in the U.S., and of this 36% of deaths occur during hospitalization, 30% of individuals die post-surgery and up to 7% of all Medicare individuals among them in 2014 were indicated with respiratory compromise--a state characterized by respiratory failures, insufficiency, respiratory arrest or death.

Market in emerging economies is expected to augment on account of recommendations by global and government healthcare organizations

North America dominates the global capnography devices market due to rampant development of advanced products in the region. Latin America capnography devices industry is experiencing a significant growth majorly due to the recommendations to use capnography in routine hospital settings by esteemed organizations and government bodies. The World Health Organization (WHO) published a report on safe surgery in 2009 that recommended the use of capnography monitoring devices during endotracheal tube placement, hypoventilation and esophageal intubation for better possible outcomes in patients. The Uruguayan Society of Anesthesiologists and the American Society of Anesthesiologists also recommends the usage of capnography monitoring in routine-use during procedural sedation and anesthetics. These guidelines by the organizations substantiate the importance of capnography equipment in hospital use.

Product innovation by market players contributing towards capnography devices market growth

Key players in capnography devices market include Dragerwerk AG & Co. KGaA., Welch Allyn, Inc., Smiths Medical, Medtronic, Inc., Philips Healthcare, Masimo, Nonin Medical, Inc., Nihon Kohden Corporation, CareFusion Corporation and Dia Medica, Inc.

Capnography Devices Market Taxonomy:

On the basis of technology, the global market is classified into:

  • Capnographs
- Mainstream capnographs
- Sidestream capnographs
- Microstream capnographs
  • Disposables

On the basis of device type, the global market is classified into:

  • Handheld
  • Stand-alone
  • Others


About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702

Resveratrol Market - Size, Share, Outlook, and Opportunity Forecast 2018-2026

Increasing launches and approvals of new resveratrol products in the market is expected to drive the global resveratrol market growth during the forecast period. For instance, in, 2016, VitaMonk, a natural products manufacturer company, expanded its portfolio with the launch of resveratrol and pterostilbene products. Resveratrol and pterostilbene are powerful antioxidants and work together to help the body to naturally boost production of adenosine triphosphate (ATP).
Request for a sample of this research report @ https://www.coherentmarketinsights.com/insight/request-sample/2267
Furthermore, rising prevalence of ageing population, cardiovascular diseases, cancer, diabetes, neurological diseases and others are expected to rise demand for resveratrol products. For instance, according to data published by the United Nations Economic and Social Commission for Asia and the Pacific (ESCAP) in 2016, Asia Pacific constituted around 60% of the world’s geriatric population. It was estimated that in 2016, around 547 million people were aged above 60 years in Asia Pacific and this number is expected to double and reach around 1.3 billion by 2050.
For instance, in February 2017, Evolva Holding SA, a Switzerland-based pharmaceutical company launched Veri-te as its brand for resveratrol. Veri-te is readily used in a wide range of consumer health applications such as food supplements (tablets, capsules, and chews), cosmetics, energy, wellness drinks, and personal care products.
In December 2016, Helix Healthstore, a natural health supplement manufacturer expanded its product portfolio with the addition of Trans- Resveratrol-Super Youth Complex products in its range of premium health supplements. Trans- Resveratrol-Super Youth Complex is a potent antioxidant supplement and contains anti-aging properties that helps to prevent cell damages caused by free radicals, maintains longevity, and promote cellular rejuvenation.
In August 2017, Jupiter Orphan Therapeutics, Inc. received U.S. Food and Drug Administration (FDA) Orphan Drug Designation for its trans-resveratrol formulation, JOTROL. Based on the phase II trial, utilizing resveratrol, conducted by the company and its partner Murdoch Children's Research Institute. JOTROL is expected to be used for the treatment of Friedreich's Ataxia.
Some side effects related with resveratrol is expected to hinder growth of the global resveratrol market during the forecast period. For instance, according to data published by National Institute of Health (NIH) in May 2018, resveratrol may cause side effects such as gastrointestinal upset, nausea, headache, and fatigue. It may also causes supplement-drug interactions with estrogens and anticoagulants, which is further expected to hinder its adoption.
Make an inquiry for purchasing this report @ https://www.coherentmarketinsights.com/insight/buy-now/2267
Key players operating in the global resveratrol market include SkinCeuticals, Evolva SA, DSM Nutritionals, Jeunesse Global, VitaMonk, Helix Healthstore, Terraternal, Andorra Life, ResVitale, LLC, Endurance Products Company, RevGenetics, SiChuan Xieli Pharmaceutical Co., Ltd., and others.

Needle-free IV Connectors Market Set For Rapid Growth By 2025


Needle-Free IV Connectors are routinely used in the hospitals for intravenous administration of fluids and medicines to protect the hubs in vascular access systems. In order to reduce risks of possible contaminations associated with the IV administration and to curb manipulation as much as possible, needle free IV connectors can prove to be ideal in all types of IV infusions. Furthermore, technological advancements such as connectors that prevent fluid reflux, highly closed systems, and connectors embedded with antimicrobial agents (V-Link) have helped to decrease the risk of bloodstream infections associated with IV administration. Needle-free connectors are with extended dwell time that can help preventing intraluminal contamination and device cross-contamination, which can be favorable for the growth of the market in the near future.


Market Dynamics

Government organizations and regulatory bodies namely Centers for Disease Control and prevention (CDC) have recommended the usage of needle-free connectors to reduce the incidence of sharp injuries and blood stream infections mandating its usage in medical facilities in the ‘Guidelines for the Prevention of Intravascular Catheter-Related Infections’ in 2011. Major issues associated with the conventional options of intravenous infusion are contamination from external sources during administration, blood reflux, and risk of bloodstream infections, which are addressed by needle-free IV connectors. The National Healthcare Safety Network (NHSN) conducts various programs worldwide that helps to impart education and hands on training sessions to all physicians and nurses about the usage of needle-free connectors and insertion of central venous catheters in children and adults. The advantages of needle-free IV connectors over conventional IV administration namely, safer access to IV lines without using needle, reduced risk of bloodstream infections and reduced possibility of contamination, rising chronic diseases prevalence and cost containment through use of needle-free IV connectors is expected to boost the growth of needle-free IV connectors market over the forecast period.

The global needle-free IV connectors market was valued at US$ 621.1 million in 2016 and is expected to reach a robust CAGR of 10.3% over the forecast period (2017-2025).

Rising incidence and prevalence of various chronic diseases and need for treatment is expected to boost the needle-free connectors market

North America accounts for the largest share in the global needle-free connectors market, followed by Europe. This is mainly attributed to the rise in the geriatric population and chronic diseases. According to the Centers for Disease Control and Prevention (CDC), 2016, about half of American adults, that is around 117 million people had one or more chronic health conditions and one in four adults had two or more chronic health conditions. The factors driving the growth of the needle-free IV connectors market includes government investments and funding to improve healthcare infrastructure, awareness in people, and healthcare practitioners.

Competitive Landscape

Some major players operating in the needle-free IV connectors market are Baxter International Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, CareFusion Corporation, ICU Medical, Inc., Nexus Medical LLC, RyMed Technologies, LLC, and Vygon SA.

Detailed Segmentation:

Global Needle-Free IV Connectors Market, By Design Type:
  • Simple
  • Complex

Global Needle-Free IV Connectors Market, By Mechanism:
  • Positive
  • Negative
  • Neutral

Global Needle-Free IV Connectors Market, By Dwell Time:
  • Seven-Day
  • Other than Seven-Day


About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702